We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWKS
1526
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$10.8K ﹤0.01%
4,287
+4,054
+1,740% +$15.5K
TGTX icon
1527
TG Therapeutics
TGTX
$7.62B
$10.8K ﹤0.01%
712
-70
-9% -$1.11K
VHT icon
1528
Vanguard Health Care ETF
VHT
$18.7B
$10.8K ﹤0.01%
40
-75
-65% -$19.7K
BBDC icon
1529
Barings BDC
BBDC
$965M
$10.8K ﹤0.01%
1,159
+131
+13% +$1.2K
BZH icon
1530
Beazer Homes USA
BZH
$907M
$10.8K ﹤0.01%
328
+2
+0.6% +$62
MLI icon
1531
Mueller Industries
MLI
$15.2B
$10.7K ﹤0.01%
398
+2
+0.5% +$49
SPEM icon
1532
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$10.7K ﹤0.01%
296
BORR
1533
Borr Drilling
BORR
$1.19B
$10.7K ﹤0.01%
1,564
+557
+55% +$3.65K
GOOD
1534
Gladstone Commercial Corp
GOOD
$627M
$10.7K ﹤0.01%
773
-27
-3% -$351
SBS icon
1535
Sabesp
SBS
$18.7B
$10.7K ﹤0.01%
3,269
PI icon
1536
Impinj
PI
$5.6B
$10.7K ﹤0.01%
83
ADAP
1537
DELISTED
Adaptimmune Therapeutics
ADAP
$10.7K ﹤0.01%
6,745
+2,135
+46% +$2.58K
GRFS
1538
Grifois
GRFS
$5.4B
$10.6K ﹤0.01%
1,593
-221
-12% -$1.73K
ALKS icon
1539
Alkermes
ALKS
$8.25B
$10.6K ﹤0.01%
393
-35
-8% -$994
AEL
1540
DELISTED
American Equity Investment Life Holding Company
AEL
$10.6K ﹤0.01%
189
MYRG icon
1541
MYR Group
MYRG
$5.25B
$10.6K ﹤0.01%
60
NEOG icon
1542
Neogen
NEOG
$2.5B
$10.6K ﹤0.01%
672
-172
-20% -$2.88K
MAN icon
1543
ManpowerGroup
MAN
$2.63B
$10.6K ﹤0.01%
136
SHAK icon
1544
Shake Shack
SHAK
$2.87B
$10.5K ﹤0.01%
101
+86
+573% +$7.53K
NYT icon
1545
New York Times
NYT
$10.2B
$10.5K ﹤0.01%
243
-16
-6% -$728
OZK icon
1546
Bank OZK
OZK
$5.61B
$10.5K ﹤0.01%
231
TGB
1547
Trekor Metals
TGB
$3.05B
$10.5K ﹤0.01%
4,828
+490
+11% +$769
ASAN icon
1548
Asana
ASAN
$2.13B
$10.5K ﹤0.01%
675
+188
+39% +$3.37K
KBH icon
1549
KB Home
KBH
$3.59B
$10.3K ﹤0.01%
146
+55
+60% +$3.51K
PB icon
1550
Prosperity Bancshares
PB
$8.89B
$10.3K ﹤0.01%
157

Similar funds

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.